Publications by authors named "Lucas Rodrigues Maia"
Article Synopsis
- COVID-19, caused by the SARS-CoV-2 virus, can lead to severe immune responses and complications like acute lung injury and organ failure, especially in patients with pre-existing immune disorders.
- A case study highlights a young female with severe Crohn's disease who successfully battled COVID-19 pneumonia while continuing treatment with adalimumab and prednisone, which control her Crohn's symptoms.
- This case suggests that TNF-α inhibitors like adalimumab may help mitigate severe COVID-19 complications by blocking the inflammatory processes associated with the disease, in addition to the effects of prednisone.
Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series.
Rev Inst Med Trop Sao Paulo
September 2020
In late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as the cause of a cluster of pneumonia cases in China, and the corresponding disease was designated as Coronavirus Disease 2019 (COVID-19), spreading quickly around the world resulting in a pandemic. COVID-19 is associated with a set of coagulation abnormalities that increase the risk of thromboembolic events, especially in patients with severe/critical disease. We describe a series of five cases of mild COVID-19, treated in an outpatient clinic, which, after an apparent clinical improvement, developed acute pulmonary embolism (APE) between the third and the fourth week after the onset of symptoms, when they are mostly related to acute illness disappearance.
View Article and Find Full Text PDF